发明公开
EP1428527A1 Novel formulations for transdermal delivery of pergolide
失效
Neue Zusammensetzungen zur transdermalen Verabrechung von Pergolid
- 专利标题： Novel formulations for transdermal delivery of pergolide
- 专利标题（中）： Neue Zusammensetzungen zur transdermalen Verabrechung von Pergolid
-
申请号： EP04075596.9申请日： 1996-06-07
-
公开(公告)号： EP1428527A1公开(公告)日： 2004-06-16
- 发明人: Yum, Su II , Nelson, Melinda K. , Campbell, Patricia S.
- 申请人： ALZA Corporation
- 申请人地址： 1900 Charleston Road, P.O. Box 7210 Mountain View, CA 94039-7210 US
- 专利权人： ALZA Corporation
- 当前专利权人： ALZA Corporation
- 当前专利权人地址： 1900 Charleston Road, P.O. Box 7210 Mountain View, CA 94039-7210 US
- 代理机构： Williams, Paul Edwin
- 优先权： US473631 19950607
- 主分类号： A61K9/70
- IPC分类号： A61K9/70 ; A61K31/48 ; A61P25/16
摘要：
Composition of matter for application to a body surface or membrane to administer pergolide by permeation through the body surface or membrane, the composition comprising pergolide to be administered, at a therapeutically effective rate, alone or in combination with a permeation enhancer or mixture. Also disclosed are drug delivery devices containing the pergolide or pergolide and enhancer composition and methods for the transdermal administration of the pergolide and pergolide/enhancer composition.
信息查询
